Cargando…

Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer

Carboplatin resistance in ovarian cancer (OV) is a major medical problem. Thus, there is an urgent need to find novel therapeutic targets to improve the prognosis of patients with carboplatin-resistant OV. Accumulating evidence indicates that the gene COL1A1 (collagen type I alpha 1 chain) has an im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Feng, Zhao, Ziyu, Cai, Shaoyi, Ling, Li, Hong, Leying, Tao, Liang, Wang, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928381/ https://www.ncbi.nlm.nih.gov/pubmed/33680916 http://dx.doi.org/10.3389/fonc.2020.576565

Ejemplares similares

MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1
por: Wang, Congjun, et al.
Publicado: (2022)

Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy
por: Opławski, Marcin, et al.
Publicado: (2022)

Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance
por: Visco, Zachary R., et al.
Publicado: (2021)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis
por: Zhang, Lihua, et al.
Publicado: (2020)

The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
por: Li, Gaofeng, et al.
Publicado: (2021)

Effectiveness and safety of weekly therapy versus 3-weekly therapy of paclitaxel plus carboplatin in women with ovarian cancer: a protocol of systematic review and meta-analysis
por: Qiu, Weitao, et al.
Publicado: (2022)

Desensitization Protocol to Carboplatin: A Technical Report
por: Nitipir, Cornelia, et al.
Publicado: (2022)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
por: Pénzváltó, Zsófia, et al.
Publicado: (2014)

Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
por: Zhang, Jing, et al.
Publicado: (2021)

COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
por: Zan, Xiangyi, et al.
Publicado: (2022)

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer
por: Penson, Richard T, et al.
Publicado: (2023)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
por: Abreu de Oliveira, Willy Antoni, et al.
Publicado: (2021)

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
por: Zhou, Hai-Hong, et al.
Publicado: (2019)

CircCSPP1 Functions as a ceRNA to Promote Colorectal Carcinoma Cell EMT and Liver Metastasis by Upregulating COL1A1
por: Wang, Qingyuan, et al.
Publicado: (2020)

RNA-Binding Protein COL14A1, TNS1, NUSAP1 and YWHAE Are Valid Biomarkers to Predict Peritoneal Metastasis in Gastric Cancer
por: Jiang, Yue, et al.
Publicado: (2022)

Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin
por: Zhang, Jinli, et al.
Publicado: (2017)

Overcoming the challenges of drug development in platinum-resistant ovarian cancer
por: Eskander, Ramez N., et al.
Publicado: (2023)

Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
por: Herath, Nirmitha I., et al.
Publicado: (2019)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII/CREB1 mediated ABCB1 expression
por: Huang, Wei, et al.
Publicado: (2022)

Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma
por: Lu, Linghui, et al.
Publicado: (2023)

COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
por: Wen, Zhihui, et al.
Publicado: (2022)

Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4
por: Zhou, Songhui, et al.
Publicado: (2020)

Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Improvement of Breast Cancer-Associated Pulmonary Tumor Thrombotic Microangiopathy With Carboplatin and Gemcitabine
por: Tran, Helen, et al.
Publicado: (2023)

P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells
por: Han, Xiangming, et al.
Publicado: (2022)

Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022
por: Liu, Jiahua, et al.
Publicado: (2023)

COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer: COM33 sensitizes ovarian cancer to carboplatin
por: Zhou, Zhiyang, et al.
Publicado: (2022)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

COL10A1 allows stratification of invasiveness of colon cancer and associates to extracellular matrix and immune cell enrichment in the tumor parenchyma
por: Kahlert, Ulf D., et al.
Publicado: (2022)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the GDNF–LIF Interaction
por: Ke, Ning, et al.
Publicado: (2022)

RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1
por: Xue, Jianxin, et al.
Publicado: (2021)

Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022
por: Liu, Jiahua, et al.
Publicado: (2023)

Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer
por: Yao, Guorong, et al.
Publicado: (2022)

Efficacy of birinapant in combination with carboplatin in targeting platinum-resistant epithelial ovarian cancers
por: Singh, Tanya, et al.
Publicado: (2022)

Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
por: Wenzel, Alexander T., et al.
Publicado: (2022)

Overexpression of ABCC1 Confers Drug Resistance to Betulin
por: Chen, Xuan-Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7v6ki57e4tgqitjbg1lcq37dp